Ads
related to: first quarter earnings reports
Search results
Medicure Reports First Quarter 2024 Earnings
Simply Wall St. via Yahoo Finance· 11 hours agoMedicure (CVE:MPH) First Quarter 2024 Results Key Financial Results Revenue: CA$5.69m (up 1.2% from 1Q 2023...Profit margin: 0.9% (down from 5.2% in 1Q...
Earnings call: Foot Locker meets market expectations despite a 1.8% decrease in sales By...
Investing.com· 10 hours agoFoot Locker , Inc. (NYSE:FL) reported a steady first quarter, with non-GAAP earnings per share (EPS)...
U-Haul Holding Co (UHAL) Q4 2024 Earnings Call Transcript Highli
Guru Focus· 31 minutes agoFourth-Quarter Loss: $863,000 compared to earnings of $37.4 million last year.Full Fiscal Year 2024 Earnings: $628.7 million compared to $924.5 million for fis
Ulta Beauty Outshines Kohl’s Ugly Earnings, But Lower Outlook Disappoints
Barrons.com· 10 hours agoUlta Beauty reported first-quarter earnings that beat per-share expectations on Thursday, but shares...
SentinelOne (S) Q1 2025 Earnings Call Transcript
Motley Fool via Yahoo Finance· 2 hours agoOur first-quarter performance surpassed our revenue, gross margin, and operating margin expectations. Once again, we delivered industry-leading revenue...
Ulta Beauty lowers guidance after first-quarter sales slowdown
NBC Chicago· 12 hours agoUlta Beauty reported on Thursday fiscal first-quarter earnings that showed the effects of a slowdown...
Earnings call: Salesforce maintains FY25 guidance amid growth focus By Investing.com
Investing.com· 11 hours agoSalesforce (NYSE:CRM) has reported its fiscal 2025 first-quarter earnings, highlighting a steady...
Earnings call: SLANG Worldwide reports a 35% year-over-year decrease in revenue By Investing.com
Investing.com· 11 hours agoSLANG Worldwide (OTC:SLGWF) has reported its financial and operational results for the firstquarter...
Earnings call: Caleres tops Q1 earnings expectations, guides steady By Investing.com
Investing.com· 12 hours agoCaleres Inc. (NYSE:CAL) has reported robust financial results for the first quarter of 2024,...
Earnings call: Cellectis reports an additional investment of $140 million from AstraZeneca By...
Investing.com· 11 hours agoIn their first quarter 2024 earnings call, Cellectis, a biopharmaceutical company, presented a...
